Skip to main content
Clinical Trials/NCT01684293
NCT01684293
Completed
N/A

Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study

University of California, San Francisco1 site in 1 country50 target enrollmentJuly 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Cognitive Impairment, So Stated
Sponsor
University of California, San Francisco
Enrollment
50
Locations
1
Primary Endpoint
Change in cognitive impairment
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study integrates a model of occupational-therapy based cognitive rehabilitation as part of a comprehensive treatment plan for cocaine abusers. We hypothesize that cognitive impairment and quality of life would improve and that cocaine use would decrease in those participants receiving occupational-therapy based cognitive rehabilitation.

Detailed Description

occupational-therapy based cognitive rehabilitation as part of a comprehensive treatment plan for cocaine abusers

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
March 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Primary cocaine use disorder (based on DSM-5 criteria) and in at least 3 months of remission
  • At least mild cognitive impairment, defined as = or \> 1.5 standard deviations impairment on any 2 performance-based neurocognitive measures
  • Needing to change quality of life, defined as self-identifying at least 2 life areas as needing to change on the Drug User Quality of Life Scale
  • A Veteran at the San Francisco Veterans Affairs Medical Center
  • Currently receiving weekly drug counseling (individual or group; at least 1 hour/week) through an outpatient substance use disorder treatment program

Exclusion Criteria

  • Inability to speak, read, write, and understand English
  • Inadequate hearing or vision
  • Concurrent substance use disorder (except tobacco or caffeine) not in at least 3 months of remission
  • A psychiatric disorder that will interfere with study participation or will make participation hazardous (e.g., psychosis, suicidal or homicidal ideations, severe anxiety)
  • A depressive disorder classified as severe, defined as a Beck Depression Inventory-II score \>29
  • Current diagnosis of a bipolar disorder needing acute inpatient psychiatric hospitalization
  • Currently symptomatic from attention-deficit/hyperactivity disorder (DSM-5 criteria)
  • Any learning disorder, any type of dementia, any type of delirium, or an amnestic disorder due to any general medical condition
  • Wechsler Test of Adult Reading standard score \<70
  • Mini-Mental State Examination score \<24

Outcomes

Primary Outcomes

Change in cognitive impairment

Time Frame: baseline through 6 months

Global Deficit Score, range 0 (no impairment) to 5 (severe impairment)

Study Sites (1)

Loading locations...

Similar Trials